Exploring the Cardiovascular Benefits of GLP-1 RAs in Patient Care
GLP-1 Cardiovascular Outcome Trials (CVOT)
GLP-1 Cardiovascular Outcome Trials (CVOT)
Semaglutide, tirzepatide, and dulaglutide achieve similar results and have similar mechanisms of action, so the choice often comes down to preference and tolerability. Glucagon-like peptide-1 receptor agonists (GLP-1) medications are used to treat patients with type 2 diabetes and obesity…